Epitopea is a transatlantic cancer immunotherapeutics company developing accessible off-the-shelf RNA immunotherapies that target aberrantly expressed tumor-specific antigens for the treatment of various cancers
Epitopea is a transatlantic cancer immunotherapeutics company developing accessible off-the-shelf RNA immunotherapies that target aberrantly expressed tumor-specific antigens for the treatment of various cancers.